130 related articles for article (PubMed ID: 23530389)
1. Coping with a pertussis outbreak in Alamance County, North Carolina.
Shapley-Quinn K
N C Med J; 2013; 74(1):68-9. PubMed ID: 23530389
[No Abstract] [Full Text] [Related]
2. Why do pertussis vaccines fail?
Cherry JD
Pediatrics; 2012 May; 129(5):968-70. PubMed ID: 22529282
[No Abstract] [Full Text] [Related]
3. Priming with whole-cell versus acellular pertussis vaccine.
Liko J; Robison SG; Cieslak PR
N Engl J Med; 2013 Feb; 368(6):581-2. PubMed ID: 23388023
[No Abstract] [Full Text] [Related]
4. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
[TBL] [Abstract][Full Text] [Related]
5. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(25):468-70. PubMed ID: 22739778
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
[TBL] [Abstract][Full Text] [Related]
7. Pertussis vaccines for adolescents and adults.
Cherry JD
Pediatrics; 2005 Sep; 116(3):755-6. PubMed ID: 16140719
[No Abstract] [Full Text] [Related]
8. What's wrong with acellular pertussis vaccines?
Wiedermann BL
Clin Ther; 2013 Feb; 35(2):115-8. PubMed ID: 23375491
[No Abstract] [Full Text] [Related]
9. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
Wilson TR
J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trials.
Van Damme P; McIntyre P; Grimprel E; Kuriyakose S; Jacquet JM; Hardt K; Messier M; Van Der Meeren O
Vaccine; 2011 Aug; 29(35):5932-9. PubMed ID: 21718738
[TBL] [Abstract][Full Text] [Related]
11. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E
Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794
[TBL] [Abstract][Full Text] [Related]
12. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.
Tapiainen T; Cherry JD; Heininger U
Vaccine; 2005 Oct; 23(43):5106-12. PubMed ID: 16023771
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of pertussis and use of acellular pertussis vaccines in Japan.
Kuno-Sakai H; Kimura M
Dev Biol Stand; 1997; 89():331-2. PubMed ID: 9272368
[No Abstract] [Full Text] [Related]
14. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
15. Number and order of whole cell pertussis vaccines in infancy and disease protection.
Sheridan SL; Ware RS; Grimwood K; Lambert SB
JAMA; 2012 Aug; 308(5):454-6. PubMed ID: 22851107
[No Abstract] [Full Text] [Related]
16. TDM Journal Club: Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis Immunization During Pregnancy.
Leibson T; St-Onge M; Koren G
Ther Drug Monit; 2015 Jun; 37(3):283-4. PubMed ID: 25271727
[No Abstract] [Full Text] [Related]
17. Pertussis vaccine controversies and acellular pertussis vaccine.
Shah RC; Shah AR
Indian J Pediatr; 2003 Jun; 70(6):485-8. PubMed ID: 12921317
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.
Wei SC; Tatti K; Cushing K; Rosen J; Brown K; Cassiday P; Clark T; Olans R; Pawloski L; Martin M; Tondella ML; Martin SW
Clin Infect Dis; 2010 Aug; 51(3):315-21. PubMed ID: 20578875
[TBL] [Abstract][Full Text] [Related]
19. Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease.
Cherry JD
N Engl J Med; 2012 Aug; 367(9):785-7. PubMed ID: 22894554
[No Abstract] [Full Text] [Related]
20. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control.
Kirkland KB; Talbot EA; Decker MD; Edwards KM
Clin Infect Dis; 2009 Aug; 49(4):584-7. PubMed ID: 19589084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
